{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:08:39Z","timestamp":1789650519508,"version":"4.0.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004219","name":"Paul Scherrer Institut","doi-asserted-by":"publisher","award":["R19-17"],"award-info":[{"award-number":["R19-17"]}],"id":[{"id":"10.13039\/501100004219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is implicated in elevating the risk for cardiovascular (CV) disease; whether the elevated risk applies to all types of CV diseases or specific types is unclear. This study examined the association of AAV and adverse CV outcomes compared with the non-AAV population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a population-based, retrospective cohort study of adults (mean age 61 years, 51% female) with a new diagnosis of AAV in Ontario, Canada from 2007 to 2017. Weighted models were used to examine the association of AAV (n\u00a0=\u00a01520) and CV events in a matched (1:4) control cohort (n\u00a0=\u00a05834). The main outcomes were major adverse CV events (MACE), defined as myocardial infarction (MI), stroke or CV death, its components, atrial fibrillation (AF) and congestive heart failure (CHF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over a mean follow-up of 3.8 years, AAV (compared with non-AAV) was associated with a higher risk of stroke: cumulative incidence 7.0% versus 5.2%, sub-distribution hazard ratio (sHR) 1.49 [(95% confidence interval (95% CI) 1.10\u20132.02]; AF: cumulative incidence 16.4% versus 11.5%, sHR 1.51, 95% CI 1.30\u20131.75; and CHF: cumulative incidence 20.8% versus 13.3%, sHR 1.41, 95% CI 1.22\u20131.62; but not for MACE, MI or CV death. The risks for all CV events, except CV death, were significantly elevated in the early period after AAV diagnosis, in particular AF (365-day sHR 2.06, 95% CI 1.71\u20132.48; 90-day sHR 3.33, 95% CI 2.66\u20134.18) and CHF (365-day sHR 1.75, 95% CI 1.48\u20132.07; 90-day sHR 2.65, 95% CI 2.15\u20133.26).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AAV is associated with a high risk of certain types of CV events, particularly in the early period following diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfab229","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T20:15:52Z","timestamp":1637266552000},"page":"681-692","source":"Crossref","is-referenced-by-count":34,"title":["Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-2030","authenticated-orcid":false,"given":"David","family":"Massicotte-Azarniouch","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Petrcich","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Canada"},{"name":"Population Health Research Institute, Hamilton Health Sciences\/McMaster University, Hamilton, Canada"},{"name":"St Joseph's Healthcare Hamilton, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Canney","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-3531","authenticated-orcid":false,"given":"Gregory L","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Milman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A","family":"Hladunewich","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Fairhead","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M","family":"Sood","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada"},{"name":"Division of Nephrology, The Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"2022033100264080400_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022033100264080400_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"De Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022033100264080400_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2022033100264080400_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2022033100264080400_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022033100264080400_bib6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.39614","article-title":"Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease","volume":"68","author":"Rhee","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022033100264080400_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022033100264080400_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022033100264080400_bib9","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLOS Med"},{"issue":"Suppl 2","key":"2022033100264080400_bib10","first-page":"kez059.016","article-title":"Utilization of Canadian healthcare administrative databases to accurately identify cases of ANCA-associated vasculitis","volume":"58","author":"Garner","year":"2019","journal-title":"Rheumatology"},{"key":"2022033100264080400_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"2022033100264080400_bib12","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"2022033100264080400_bib13","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"2022033100264080400_bib14","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"2022033100264080400_bib15","author":"Cohen"},{"key":"2022033100264080400_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2022033100264080400_bib17","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/ndt\/gft355","article-title":"When do we need competing risks methods for survival analysis in nephrology?","volume":"28","author":"Noordzij","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022033100264080400_bib18","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1002\/sim.7084","article-title":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis","volume":"35","author":"Austin","year":"2016","journal-title":"Stat Med"},{"key":"2022033100264080400_bib19","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/art.39762","article-title":"Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (Wegener's): a population-based study","volume":"68","author":"Avi\u00f1a-Zubieta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022033100264080400_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-12-41","article-title":"Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"12","author":"Z\u00f6ller","year":"2012","journal-title":"BMC Neurol"},{"key":"2022033100264080400_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/pds.4116","article-title":"Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases","volume":"25","author":"Sreih","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022033100264080400_bib22","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/art.24957","article-title":"Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022033100264080400_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022033100264080400_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mayocp.2018.02.010","article-title":"Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20-year population-based cohort study","volume":"93","author":"Berti","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2022033100264080400_bib25","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2022033100264080400_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"2022033100264080400_bib27","doi-asserted-by":"crossref","first-page":"e015977","DOI":"10.1161\/JAHA.120.015977","article-title":"Association of autoimmune vasculitis and incident atrial fibrillation: a population-based case-control study","volume":"9","author":"Melduni","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022033100264080400_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","article-title":"Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids","volume":"83","author":"Ettinger","year":"1987","journal-title":"Am J Med"},{"key":"2022033100264080400_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(75)90575-6","article-title":"The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients","volume":"58","author":"Bulkley","year":"1975","journal-title":"Am J Med"},{"key":"2022033100264080400_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"2022033100264080400_bib31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"2022033100264080400_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"2022033100264080400_bib33","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"2022033100264080400_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/hrt.2006.088443","article-title":"Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis","volume":"93","author":"Chironi","year":"2007","journal-title":"Heart"},{"key":"2022033100264080400_bib35","first-page":"18","article-title":"Patients with Wegener's granulomatosis: a long-term follow-up study","volume":"28","author":"de Leeuw","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2022033100264080400_bib36","first-page":"1875","article-title":"Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis","volume":"34","author":"Nienhuis","year":"2007","journal-title":"J Rheumatol"},{"key":"2022033100264080400_bib37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"2022033100264080400_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2016010105","article-title":"AKI and long-term risk for cardiovascular events and mortality","volume":"28","author":"Odutayo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022033100264080400_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2215\/CJN.12591117","article-title":"Acute kidney injury and risk of heart failure and atherosclerotic events","volume":"13","author":"Go","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022033100264080400_bib40","doi-asserted-by":"crossref","first-page":"e3005","DOI":"10.1097\/MD.0000000000003005","article-title":"The association of acute kidney injury and atrial fibrillation after cardiac surgery in an Asian prospective cohort study","volume":"95","author":"Ng","year":"2016","journal-title":"Medicine"},{"key":"2022033100264080400_bib41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.amjmed.2009.04.022","article-title":"Risk factors for heart failure: a population-based case-control study","volume":"122","author":"Dunlay","year":"2009","journal-title":"Am J Med"},{"key":"2022033100264080400_bib42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"2022033100264080400_bib43","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfab229\/42098028\/sfab229.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/4\/681\/43057937\/sfab229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/4\/681\/43057937\/sfab229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:27:37Z","timestamp":1648686457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/15\/4\/681\/6438449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,24]]},"published-print":{"date-parts":[[2022,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfab229","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2021,11,24]]}}}